Infectious Diseases in Critical Care Medicine

39. Morpeth S, Murdoch D, Cabell C. Non- HACEK Gram-negative bacillus endocarditis Ann Intern
    Med 2007; 47:829–835.


40. Das M, Badley AD, Cockerill FR, et al. Infective endocarditis caused by HACEK microorganisms.
    Ann Rev Med 1997; 28:25–32.


41. Legakis N. Variations in the prevalence of strains expressing an extended spectrum beta-lactamase
    phenotype and characterization of isolates from Europe, The Americas and the Western Pacific
    region. Clin Infect Dis 2001; 32(suppl 2): S94–S98.


42. Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella
    pneumonia bacteremia: Implications of extended spectrum beta-lactamase production and
    nosocomial infections. Ann Intern Med 2004; 140:26–32.


43. Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter, Wounding. Curr
    Opin Infect Dis 2005; 18:502–506.


44. Valencia-Ortega ME, Enriquez CA, Guinea EJ, et al. Polymicrobial endocarditis: a clinical and
    evolutive study of two cases diagnosed during a 10 year period. Rev Clin Esp 1997; 197:245–247.


45. Martin GS, Mannino GM, Eaton J, et al. The epidemiology of sepsis in the United States from 1979
    through 2000. N Engl J Med 2003; 348:1546–1554.


46. Leaf H, Simberkoff MS. Fungal endocarditis. In: Horstkotte D, Bodnar E, eds. Infective Endocarditis.
    London: ICR Publishers, 1991:118–134.


47. Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis evidence in world literature,
    1965–1995. Clin Infect Dis 2001; 32:50–62.


48. Nguyen MH, Nyugen ML, Yu VL, et al. Candida prosthetic valve endocarditis: prospective study of
    six cases and review of the literature. Clin Infect Dis 1996; 22:262–267.


49. Brusch JL. Diagnosis of infective endocarditis I. In: Brusch JL, ed. Infective Endocarditis:
    Management in the Era of Intravascular Devices, Ch. 12. New York, NY: Informa Health Care,
    2007:241–254.


50. Pesanti EL, Smith IM. Infective endocarditis with negative blood cultures: an analysis of 52 cases.
    Am J Med 1979; 66:43–46.


51. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over
    25 years. Heart 2003; 89:258–262.


52. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center. Medicine 2005;
    84:162–173.


53. Friedland G, Von Reyn CF, Levy BS, et al. Nosocomial endocarditis. Infect Control 1984, 5, 284–283.


54. Fernandez-Guerrero ML, Verdejo C, Azofra J, et al. Hospital-acquired infectious endocarditis not
    associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995; 20:16–23.


55. Fowler VG jr, Sanders LL, Kong LK. Infective endocarditis due to staphylococcus aureus: 59
    prospectively identify cases with follow-up. Clin Infect Dis 1999; 28:106–114.


56. Safar N, Kluger D, Maki D. A review of risk factors for catheter related bloodstream infection
    caused by percutaneously inserted noncuffed central venous catheters. Medicine 2002; 81:466–474.


57. Terpenning MS. Infective endocarditis. Clin Geriatr Med 1992; 8:903–912.


58. Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley,
    1988–1990. Am J Cardiol 1995; 76:933–936.


59. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis. Lessons
    from the International Collaboration of Endocarditis. Cardiol Clin 2003; 21:147–158.


60. Bayer AS. Infective endocarditis. Clin Infect Dis 1993; 17:313.


61. Hogevick H, OlaisonL, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an
    urban population: A 5 year prospective study. Medicine (Baltimore) 1995; 74:324–339.


62. Von Reyn CF, Levy BS, Arbeit RD, et al. Infective endocarditis:an analysis based on strict case
    definitions. Ann Int Med 1981; 94(Part 1): 505–518.


63. Tleyjeh IM, Steckleberg JM, Murad HS, et al. Temporal trends in infective endocarditis: Population
    based study in Olmsted County, Minnesota. JAMA 2005; 299:3022–3028.


64. Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors of
    6-month mortality; a prospective cohort study, Eur Heart J 2007; 28:196–203.


65. Gladstone JL, Rocco R. Host factors in infectious disease in the elderly. Med Clin North Am 1976;
    60:1225–1226.


66. Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in young and
    elderly patients. Am J Med 1987; 83:626–634.


67. Watanakunakorn C, Burkert T. Infective endocarditis in a large community teaching hospital,
    1988–1990: a review of 210 episodes. Medicine (Baltimore) 1993; 72:90–102.


68. Cooper H, Brady J, Ciccarone D, et al. Nationwide increase in the number of hospitalizations for
    illicit injection use-related infective endocarditis. Clin Infect Dis 2007; 45:1200–1203.

Infective Endocarditis and Its Mimics in Critical Care 251